Search clinical trials for: Abemaciclib Aromatase Inhibitor
Total 64432 results
-
Prof. Wolfgang JanniEli Lilly and CompanyRecruitingHormone Receptor-positive Metastatic Breast Cancer | HER2-negative Metastatic Breast CancerGermany, Switzerland
-
Eli Lilly and CompanyWithdrawnMetastatic Breast CancerUnited States, Taiwan, Italy, Austria, Germany, Puerto Rico, Belgium, Argentina, Brazil
-
Mridula George, MDRecruiting
-
Alison StopeckEli Lilly and Company; AstraZenecaWithdrawnLocally Advanced Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer FemaleUnited States
-
Eli Lilly and CompanyCompletedBreast Neoplasms | Neoplasm MetastasisIndia
-
Dana-Farber Cancer InstituteEli Lilly and CompanyWithdrawnBreast Cancer
-
PfizerCompletedMetastatic Breast CancerSpain, Belgium, Sweden, United Kingdom, Austria, Germany, Switzerland
-
Eli Lilly and CompanyActive, not recruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Endometrial CancerUnited States, Spain, France, Belgium, Taiwan, Australia, Korea, Republic of, Japan
-
Nader SanaiEli Lilly and Company; Barrow Neurological Institute; Ivy Brain Tumor CenterNot yet recruiting
-
Gynecologic Oncology GroupEli Lilly and CompanyActive, not recruiting
-
University of Texas Southwestern Medical CenterEli Lilly and Company; Cancer Prevention Research Institute of TexasRecruitingBreast CancerUnited States
-
University of Milano BicoccaActive, not recruiting
-
University of ArizonaGeorge Washington UniversityRecruiting
-
Weill Medical College of Cornell UniversityEli Lilly and CompanyRecruitingBladder CancerUnited States
-
Universitaire Ziekenhuizen KU LeuvenEli Lilly and Company; European Network of Gynaecological Oncological Trial... and other collaboratorsRecruitingLow Grade Serous Ovarian Carcinoma | Adult Type Granulosa Cell TumorBelgium, Netherlands, France
-
PfizerCompleted
-
PfizerCompletedMetastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterEli Lilly and CompanyActive, not recruiting
-
Gustave Roussy, Cancer Campus, Grand ParisCompleted
-
Medical College of WisconsinRecruitingSoft Tissue Sarcoma | Osteosarcoma | ChondrosarcomaUnited States
-
Eli Lilly and CompanyCompletedHealthyUnited States
-
Eli Lilly and CompanyCompleted
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); GlaxoSmithKline; Genentech, Inc.; Brain Science...RecruitingIntracranial Meningioma | Recurrent Meningioma | NF2 Gene MutationUnited States
-
The Affiliated Hospital of Qingdao UniversityNot yet recruitingNeoplasms | Breast Cancer | Breast DiseasesChina
-
National Cancer Institute (NCI)RecruitingKaposi SarcomaUnited States
-
National Cancer Institute (NCI)RecruitingNeurofibromatosis 1United States
-
Dana-Farber Cancer InstituteEli Lilly and CompanyRecruiting
-
Seoul National University HospitalUnknownHead and Neck Neoplasms | HNSCCKorea, Republic of
-
Memorial Sloan Kettering Cancer CenterEli Lilly and Company; Incyte CorporationRecruitingMyelofibrosis Due to and Following Polycythemia VeraUnited States
-
Nader SanaiEli Lilly and Company; Barrow Neurological Institute; Ivy Brain Tumor CenterRecruitingGlioma | Glioblastoma | GBMUnited States
-
Case Comprehensive Cancer CenterRecruitingSmall-cell Lung Cancer | Large Cell Neuroendocrine Carcinoma of the Lung | Extrapulmonary Small Cell CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterEli Lilly and CompanyActive, not recruitingSarcoma | Dedifferentiated LiposarcomaUnited States
-
Emory UniversityCompletedDiffuse Intrinsic Pontine Glioma | Brain Tumor, Recurrent | Solid Tumor, Recurrent | Neuroblastoma, Recurrent, Refractory | Ewing Sarcoma, Recurrent, Refractory | Rhabdomyosarcoma, Recurrent, Refractory | Osteosarcoma, Recurrent, Refractory | Rhabdoid Tumor, Recurrent, RefractoryUnited States
-
Eli Lilly and CompanyCompletedMetastatic Cancer | Advanced CancerChina
-
Eli Lilly and CompanyCompleted
-
Borstkanker Onderzoek GroepActive, not recruitingBreast Neoplasm FemaleNetherlands
-
Sarcoma Alliance for Research through CollaborationEli Lilly and CompanyRecruitingAdvanced Dedifferentiated LiposarcomaUnited States
-
Eli Lilly and CompanyActive, not recruitingBreast CancerCanada, Germany, Australia, Japan, United States, Taiwan, Belgium, New Zealand, Italy, Israel, Spain, France, Netherlands, Mexico, Turkey, United Kingdom, Korea, Republic of, Austria, Puerto Rico, Sweden, Russian Federation, Greece, Slovaki...
-
Duke UniversityActive, not recruitingMetastatic Breast Cancer | Locally Advanced Breast Cancer | Hormone Receptor Positive TumorUnited States
-
Dartmouth-Hitchcock Medical CenterActive, not recruiting
-
National Taiwan University HospitalRecruitingBreast Cancer | Hormone Receptor-positive Breast Cancer | Hormone TherapyTaiwan
-
Dana-Farber Cancer InstituteEli Lilly and CompanyTerminatedBreast CancerUnited States
-
Eli Lilly and CompanyAvailableMetastatic Breast CancerAustralia, Canada, Egypt, India, Italy, Korea, Republic of, Malaysia, Singapore, South Africa, Spain, Switzerland, Taiwan, Thailand, United Kingdom
-
Eli Lilly and CompanyCompleted
-
Milton S. Hershey Medical CenterEli Lilly and CompanyTerminatedBiliary Tract CarcinomaUnited States
-
Eli Lilly and CompanyCompletedLymphoma | Neoplasm MetastasisJapan
-
Anita TurkEli Lilly and CompanyTerminatedCancer | Cancer Metastatic | BRAF V600E | MEK1 Gene Mutation | MEK2 Gene Mutation | ERK Mutation | RAF1 Gene MutationUnited States
-
Stephen Bagley, MD, MSCEUniversity of Pennsylvania; Abramson Cancer Center at Penn MedicineActive, not recruiting
-
Dana-Farber Cancer InstituteEli Lilly and CompanyActive, not recruiting
-
Jules Bordet InstituteEli Lilly and CompanyCompletedCholangiocarcinoma | Endometrial Cancer | Esophageal Adenocarcinoma | Urothelial/Bladder Cancer, Nos | Esophagus SCCFrance, Belgium